Pfizer Payments For (Proceeds From) Short Term Investments With Original Maturities Of Three Months Or Less increased by 35.8% to $792.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 79.4%, from $3.85B to $792.00M.
other_payments_for_proceeds_from_short_term_investments__5c5d63| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $6.65B | $936.00M | -$3.41B | $6.56B | $7.72B | -$4.67B | $15.88B | -$5.12B | -$11.28B | $1.19B | -$4.73B | -$487.00M | $3.85B | $583.00M | $792.00M |
| QoQ Change | — | — | -85.9% | -464.2% | +292.5% | +17.7% | -160.4% | +440.5% | -132.2% | -120.4% | +110.5% | -498.1% | +89.7% | +891.0% | -84.9% | +35.8% |
| YoY Change | — | — | — | — | — | +16.2% | -36.8% | +142.0% | -166.2% | — | +125.4% | -129.8% | +95.7% | +224.5% | — | -79.4% |